Neurochemistry of major depression: a study using magnetic resonance spectroscopy
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
RATIONALE: Magnetic resonance spectroscopy (MRS) is an acceptable non-invasive means of studying brain neurochemistry in depression. Previous studies in depressed patients have focused on measurement of the amino acid neurotransmitters, γ-aminobutyric acid (GABA) and glutamate. OBJECTIVES: The aim of this study is to use MRS in conjunction with the ultrashort echo time 'SPECIAL' technique to measure cortical levels of GABA, glutamate and glutathione (GSH) levels in unmedicated patients with major depression. We also examined the effect of 6-week treatment with the selective serotonin re-uptake inhibitor, escitalopram. METHODS: We studied patients with DSM-IV major depression and healthy age-matched controls using proton MRS. GABA, glutamate and GSH were measured relative to creatine in a voxel placed in occipital cortex. RESULTS: There was no difference in GABA or glutamate levels between depressed participants and controls; however, depressed patients had lower GSH levels. Six-week escitalopram treatment, which resulted in significant clinical responses in some patients, did not alter concentrations of GABA, glutamate or GSH. CONCLUSIONS: The sources of variability of GABA and glutamate measures in different studies of depressed patients require further study. Our results suggest that concomitant treatment with selective serotonin re-uptake inhibitors (SSRIs) is unlikely to be an important confounding factor. If lowered GSH levels can be confirmed, they may represent the presence of oxidative stress in some depressed patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In line with the hypothesis that antidepressant medications might exert their effects by normalizing negative emotional biases before changes in symptoms, eventual week 6 responders showed greater reduction in neural responses to fearful vs. happy faces after 7 days of escitalopram treatment in the pgACC, dACC and amygdala [197].”
From Prefrontal cortex and depression (2022) · cites this paper as [197]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032 · cited 2×
“Mood ratings were measured using the Hamilton Rating Scale for depression (HAM-D) (Hamilton 1960) and the Beck Depression Inventory (BDI) (Beck et al. 1961), while anxiety ratings were scored using the Spielberger’s State-Trait Anxiety Inventory (Spielberger et al. 1993).”
MethodHamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 6×
“Mood ratings were measured using the Hamilton Rating Scale for depression (HAM-D) (Hamilton 1960) and the Beck Depression Inventory (BDI) (Beck et al. 1961), while anxiety ratings were scored using the Spielberger’s State-Trait Anxiety Inventory (Spielberger et al. 1993).”
MethodInfluential(1970) · Cited by 24,983
Scoville, W. B. (1949) · Journal of neurosurgery · doi:10.3171/jns.1949.6.1.0065 · Cited by 7,380
Estimation of metabolite concentrations from localized in vivo proton NMR spectra
Provencher, S. W. (1993) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910300604 · Cited by 3,655 · cited 2×
“Following spectral processing, SPECIAL data were analysed with LCModel version 6.2-2B (Provencher 1993) using a basis set that consisted of 21 simulated metabolite basis spectra.”
MethodInfluentialStructured clinical interview for DSM-IV axis I disorders : SCID-I : clinical version : scoresheet
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1997) · American Psychiatric Press eBooks · Cited by 3,101
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2462 · Cited by 894 · cited 2×
“Particular attention has focused on levels of the amino acid neurotransmitters, glutamate and γ-aminobutyric acid (GABA) because of their postulated role in the pathophysiology of depression (Taylor et al. 2003; Sanacora et al. 2008; Sanacora 2010).”
BackgroundMethodMajor depressive disorder: new clinical, neurobiological, and treatment perspectives
Kupfer, D. J., Frank, E., & Phillips, M. L. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60602-8 · Cited by 894 · cited 2×
“While some investigations have found decreases in grey matter in certain brain regions in depression, the occipital cortex is not usually implicated (Kupfer et al. 2012).”
BackgroundHasler, G., van der Veen, J. W., Tumonis, T., Meyers, N., Shen, J., & Drevets, W. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.193 · Cited by 846 · cited 3×
“GABA concentrations are also reported to be lowered in depression, particularly in occipital cortex where GABA is easier to measure with current MRS methodology (Sanacora et al. 1999, 2004; Hasler et al. 2007).”
BackgroundResultSubtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major Depression
Sanacora, G., Gueorguieva, R., Epperson, C. N., Wu, Y.-T., Appel, M., Rothman, D. L., Krystal, J. H., & Mason, G. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.705 · Cited by 796 · cited 5×
“GABA concentrations are also reported to be lowered in depression, particularly in occipital cortex where GABA is easier to measure with current MRS methodology (Sanacora et al. 1999, 2004; Hasler et al. 2007).”
BackgroundResultInfluential
Cited by
Prefrontal cortex and depression
Pizzagalli, D. A., & Roberts, A. C. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01101-7 · Cited by 667
“happy faces after 7 days of escitalopram treatment in the pgACC, dACC and amygdala [197].”
MethodA Meta-analysis of oxidative stress markers in depression
Liu, T., Zhong, S., Liao, X., Chen, J., He, T., Lai, S., & Jia, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138904 · Cited by 485
“Lower glutathione (GSH) levels [12] and a negative relationship between anhedonia severity and occipital GSH levels [13] were found through magnetic resonance spectroscopy (MRS).”
BackgroundMoriguchi, S., Takamiya, A., Noda, Y., Horita, N., Wada, M., Tsugawa, S., Plitman, E., Sano, Y., Tarumi, R., ElSalhy, M., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0252-9 · Cited by 357
Godfrey, K. E. M., Gardner, A. C., Kwon, S., Chea, W., & Muthukumaraswamy, S. D. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.08.015 · Cited by 206
The role of oxidative and nitrosative stress in accelerated aging and major depressive disorder
Maurya, P. K., Noto, C., Rizzo, L. B., Rios, A. C., Nunes, S. O. V., Barbosa, D. S., Sethi, S., Zeni, M., Mansur, R. B., Maes, M., et al. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.08.016 · Cited by 171
Metadata
- Authors
- Godlewska, B. R., Near, J., & Cowen, P. J.
- Affiliations
- Warneford Hospital (GB)
- Corresponding author
- Cowen, Philip J.
- Venue
- Psychopharmacology
- Published
- 2014-07-31
- Volume
- 232
- Issue
- 3
- Pages
- 501-507
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- PMC
- PMC4302231
- OpenAlex
- W2066809233
- Cited by
- 97
- References
- 36
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 8 · 2023: 12 · 2022: 7 · 2021: 8 · 2020: 9 · 2019: 9 · 2018: 7 · 2017: 16 · 2016: 6 · 2015: 8
- FWCI
- 7.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Psychopharmacology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- major depressive disorder, brain neurochemistry, glutathione, GABA, glutamate, selective serotonin reuptake inhibitors, escitalopram, oxidative stress, occipital cortex, 1H NMR, untreated depression
- MeSH terms
- Adult, Major Depressive Disorder, Depressive Disorder, Major, Female, gamma-Aminobutyric Acid, Glutathione, Humans, Male, Magnetic Resonance Spectroscopy, Citalopram, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neurochemistry of major depression: a study using magnetic resonance spectroscopy. https://app.cochat.ai/papers/10.1007/s00213-014-3687-y
- The paper
- Godlewska, B. R., Near, J., & Cowen, P. J. (2015). Neurochemistry of major depression: a study using magnetic resonance spectroscopy. Psychopharmacology. https://doi.org/10.1007/s00213-014-3687-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.